title: Effects of BQ-123, an ETA recepter-selective antagonist, on changes of intraocular pressure, blood-aqueous barrier and aqueous prostaglandin concentrations caused by endothelin-1 in rabbit.
abstract: Endothelin-1 (ET-1) is known to affect the intraocular pressure (IOP) in rabbits. We reported that intravitreally administered ET-1 induced biphasic IOP response, an early transient IOP rise followed by a subsequent prolonged decrease. In an attempt to clarify the role of ET receptor subtypes in the IOP responses following ET-1 injection, we studied the effects of ETA receptor-specific antagonist, BQ-123, in rabbits. We also evaluated the possible role of prostaglandins (PGs) and the disruption of the blood-aqueous barrier (BAB) following ET-1 injection in modulating the IOP change. BQ-123 (126.5 or 12.6 micrograms) was injected into the vitreous (20 microL/eye) of one eye in a group of 5 rabbits. Contralateral eyes received the same amount of vehicle in a masked randomized fashion. The same amount of ET-1 (0.5 or 0.05 micrograms) was injected intravitreally 30 minutes later into both eyes. IOP was measured prior to and periodically up to 120 hours after injection using a calibrated pneumatonometer. In another experiment BQ-123 (126.5 micrograms) was injected into one eye of 4 rabbits and the other eye served as a control to observe the effect of BQ-123 on the IOP. One hour and 24 hours following the injection of BQ-123 and ET-1, approximately 100 microL of aqueous humor was withdrawn by paracentesis. Protein concentration was measured by Lowry's method and PGE2 concentration, by radioimmunoassay. BQ-123 had no effect on the IOP when used alone. When used in combination with ET-1, BQ-123 (126.5 micrograms) significantly inhibited both the IOP rise (0.5-1 hour) and the reduction (24-72 hours) caused by ET-1 (0.5 microgram). BQ-123 (12.6 micrograms) also significantly inhibited the IOP reduction (6-8 hours and 72-96 hours) caused by ET-1 (0.05 micrograms). Pre-injection of BQ-123 (126.5 micrograms) significantly suppressed the increase in the aqueous protein and the PGE2 concentration both at 1 and 24 hours. The IOP response and the elevation of aqueous protein and PGE2 concentration following ET-1 injection are at least partly mediated by ETA receptors.
authors: Department of Ophthalmology, Gifu University School off Medicine, Japan.
authors: M S
authors: MS
authors: Haque
authors: K
authors: K
authors: Sugiyama
authors: T
authors: T
authors: Taniguchi
authors: Y
authors: Y
authors: Kitazawa
mesh_terms: D000818:Animals; D001082:Aqueous Humor / Q000187:drug effects / Q000378:metabolism*; D018916:Blood-Aqueous Barrier / Q000187:drug effects* / Q000502:physiology; D015232:Dinoprostone / Q000378:metabolism*; D004338:Drug Combinations; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000494:pharmacology*; D005136:Eye Proteins / Q000378:metabolism; D005260:Female; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D010456:Peptides, Cyclic / Q000494:pharmacology*; D011817:Rabbits; D011863:Radioimmunoassay
chemical_list: D004338:Drug Combinations; D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D005136:Eye Proteins; D010456:Peptides, Cyclic; D015232:Dinoprostone; C072247:cyclo(Trp-Asp-Pro-Val-Leu)